QSO Memo 20-22 Guidance for Infection Control and Prevention of COVID-19 in Outpatient Settings: FAQs and Considerations

Please share this individuals in the following roles: CEO, COO, CNO, Chief Medical Officer Quality Director, Director of Surgery Services, Director of Outpatient Services Infection Control Coordinator, Emergency Preparedness Coordinator, Accreditation Coordinator CMS QSO-20-22 Guidance for Infection Control and Prevention of Coronavirus Disease (COVID19) in Outpatient Settings: FAQs and Considerations Key points: This CMS QSO…

Read more

QSO Memo 20-15 (Revised 3/30/2020) – (Hospitals and CAHs)

Please share this announcement with individuals in the following roles: CEO, COO, CNO, Quality Director, Chief Medical Officer, Quality Director, Infection Control Coordinator, Emergency Preparedness Coordinator, Accreditation Coordinator CMS QSO-20-15 EMTALA Requirements and Implications Related to COVID-19 (Revised 3/30/2020) Key points: This publication provides additional guidance for the establishment of drive-through testing sites, clarification of…

Read more

QSO Memo 20-13 Revised (Hospitals and CAHs)

Please share this announcement with individuals in the following roles: CEO, COO, CNO, Chief Medical Officer Quality Director Infection Control Coordinator, Emergency Preparedness Coordinator, Accreditation Coordinator CMS QSO-20-13 Guidance for Infection Control and Prevention of COVID-19 – Revised  Key points: CMS has waived a number of requirements under Section 1135 of the Social Security Act…

Read more

QSO Memo 20-21 CLIA: Laboratory guidance during COVID-19 public health emergency

March 26, 2020 – CMS is issuing this memorandum to laboratory surveyors to provide important guidance to surveyors and laboratories during the COVID-19 public health emergency, such as: CMS’ Exercise of enforcement discretion to ensure pathologists may review pathology slides remotely if certain defined conditions are met Ensuring that laboratories located in the United States…

Read more